HERPES: Vaccines for HSV

This publication has 19 references indexed in Scilit:

• Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
  New England Journal of Medicine, 1997
• Construction and Characterization of a Replication-Defective Herpes Simplex Virus 2 ICP8 Mutant Strain and Its Use in Immunization Studies in a Guinea Pig Model of Genital Disease
  Virology, 1997
• Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
  Journal of General Virology, 1997
• A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease
  The Journal of Infectious Diseases, 1997
• DNA Immunization against Experimental Genital Herpes Simplex Virus Infection
  The Journal of Infectious Diseases, 1996
• Nucleic Acid Vaccine Encoding gD2 Protects Mice from Herpes Simplex Virus Type 2 Disease
  The Journal of Infectious Diseases, 1996
• A Recombinant Glycoprotein Vaccine for Herpes Simplex Type 2: Safety and Efficacy
  Annals of Internal Medicine, 1995
• A vaccinia virus — herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice
  Medical Microbiology and Immunology, 1994
• Contemporary Approaches to Vaccination Against Herpes Simplex Virus
  Published by Springer Nature ,1992
• Formolized Herpes Virus Therapy and the Neutralizing Substance in Herpes Simplex11From the Dermatology Department, Vanderbilt Clinic (Professor J. Gardner Hopkins); the Bacteriology Department) College of Physicians and Surgeons, (Professor Frederick P. Gay), and the New York Post-Graduate Medical School and Hospital, Skin and Cancer Unit, (George M. MacKee, Director), of Columbia University.
  Journal of Investigative Dermatology, 1938